On Cancer

Search by keywords:

and/or
Show search filters

Explore by tags:

810 Blog posts found

Event

Cycle for Survival 2014 Raises $20 Million

Cycle for Survival, Memorial Sloan Kettering’s indoor team cycling fund-raiser, raises money exclusively for research on rare cancers.

In the Clinic

Wiping Out Epstein-Barr Virus Preserves Transplant Success

Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.

Pictured: Susan Prockop & Lucas T.

Perspective

When "Do No Harm" Means "Do Nothing": Evolving Protocols

Our conversation about active surveillance of prostate cancer continues. Let's take a closer look at our protocols for selecting and monitoring patients.

Vincent Laudone

In the Lab

Bacteria May Hold the Key to Preventing Dangerous Side Effect of Transplants

Research suggests that the presence of a type of bacteria called Blautia, which occurs naturally in the body, may prevent graft-versus-host disease, a potentially fatal side effect of bone marrow and stem cell transplants.

Pictured: Marcel van den Brink & Robert Jenq

In the Lab

Holding On and Hiding Out: How Cancer Cells Spread to the Brain and Thrive

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.

Pictured: Cancer cell on blood vessel

Honor

Memorial Sloan Kettering’s Expertise Stands Out at Transplant Meeting

Memorial Sloan Kettering’s leadership in blood and marrow stem cell transplantation is on full display at the 2014 BMT Tandem Meeting.

Pictured: Sergio Giralt

Cancer Guide

New Information about Diagnosing and Treating Liver Cancer at Memorial Sloan Kettering

Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.

Pictured: William Jarnagin

Ask the Expert

Why Am I Hearing So Much About CyberKnife?

CyberKnife is a brand name for one of several available devices that deliver intense doses of radiation with very high accuracy.

Pictured: Abraham Wu

In the Clinic

New Trial Advances Cell-Based Immune Therapy for Certain Leukemias

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain

At Work: Physician-in-Chief José Baselga

Memorial Hospital’s Physician-in-Chief José Baselga talks about highlights from 2013 and the future of Memorial Sloan Kettering’s clinical enterprise.

Pictured: José Baselga